PubMed Health⌕ Search

PubMed · 9799131

Pulmonary host defenses.

Abstract

The lung is constantly exposed to invading particulate matter and potential pathogens. To cope with this pressure, the lung has evolved a sophisticated, multitiered defense mechanism designed to clear offending agents while inducing a minimum amount of concomitant inflammation. Mechanical defense mechanisms first attempt to remove material physically from the tracheobronchial tree. Particulate matter and pathogens that circumvent this first line of defense are ingested by resident and recruited phagocytes in the lower respiratory tract and alveoli. If phagocytic defenses are impaired or overwhelmed, specific immune mechanisms become operational and lead to the generation of delayed-type hypersensitivity (granulomatous), cytotoxic, and humoral (antibody) responses. Congenital or acquired impairment of pulmonary host defenses can occur at any of these steps. Impairment of a particular component of pulmonary host defense is usually associated with a characteristic spectrum of infectious and noninfectious pulmonary complications. Thus, understanding all the components of pulmonary host defense and how to evaluate them will greatly aid the physician who cares for immunocompromised patients with lung disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H L Twigg. 1998. Pulmonary host defenses.. https://doi.org/10.1097/00005382-199810000-00003

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Analysis of HLA class I specific antibodies in patients with failed allografts.

BACKGROUND: The goals of this study are first to determine the epitope specificity of donor specific antibody (DSA) in the serum of alloimmunized transplant patients with a failed renal graft; and second to understand the correlation between the development of DSA and nondonor specific antibody (NDSA). METHODS: The sera of 35 pretransplant panel reactive antibody (PRA)-negative patients with failed allografts were examined with single-antigen (SA) luminex beads to identify human leukocyte antigen (HLA)-A and -B antibodies. Potential HLA antibody epitopes were identified by using computer software and verified by absorption and elution from single-antigen cell lines. RESULTS: Twenty-seven patients developed donor-specific HLA-A and/or -B antibodies, while the remaining eight patients had only nondonor-specific HLA-A and/or -B antibodies. The DSA-positive patients also had a long list of NDSA. Sixty-eight percent of the reactions found in 27 recipients with DSA were attributable to 66 epitopes on the mismatched donor HLA molecule. All 39 NDSA in eight patients with only NDSA shared 17 epitopes within positive allele specificities. By absorption and elution using recombinant cell lines having a single HLA specificity, we confirmed the epitopes involved in three patients. CONCLUSION: Development of most NDSA in patients with failed allografts is likely due to sharing epitopes with DSA and/or other NDSA.

Antibody Formation↗

Human keratinocyte Toll-like receptors promote distinct immune responses.

It has been well established that Toll-like receptors (TLRs) are expressed by keratinocytes and respond to their respective ligands to initiate immune responses. However, it appears that keratinocytes, via differential activation of TLRs, may play a key role in determining the type of subsequent cutaneous immune response generated against a particular pathogen.

Antibody Formation↗